Business Context and Reporting Period
This Form 8-K Current Report, dated January 21, 2021, covers The Chemours Company (Chemours). The filing details a binding Memorandum of Understanding (MOU) entered into on January 22, 2021, with DuPont de Nemours, Inc., Corteva Inc., and E. I. du Pont de Nemours and Company (EID). The agreement addresses the sharing of future legacy liabilities related to per- and polyfluoroalkyl substances (PFAS) arising from pre-July 1, 2015 conduct, and the settlement of specific PFOA litigation.
Key Financial Metrics and Obligations
- PFAS Liability Sharing: Chemours agreed to bear 50% of future potential legacy PFAS liabilities, with DuPont and Corteva collectively bearing the remaining 50%. This arrangement lasts until the earlier of December 31, 2040, or when aggregate "Qualified Spend" reaches $4 billion.
- Escrow Funding Commitments:
- 2021-2022: Chemours to deposit $100 million annually; DuPont and Corteva to deposit $100 million in aggregate annually.
- 2023-2028: Chemours to deposit $50 million annually; DuPont and Corteva to deposit $50 million in aggregate annually.
- Replenishment: If the escrow balance is below $700 million on December 31, 2028, Chemours and the other parties must make equal deposits to restore the balance.
- PFOA Litigation Settlement: A settlement of approximately $83 million was reached for consolidated personal injury cases in Ohio and West Virginia. Chemours' contribution is approximately $29 million, with DuPont and Corteva each contributing approximately $27 million.
- Accruals: Chemours had accrued approximately $29 million for this PFOA matter as of December 31, 2020.
Material Changes and Agreements
The filing represents a material change in the management of legacy liabilities. Chemours, DuPont, and Corteva agreed to release certain claims regarding Chemours' Delaware lawsuit and pending confidential arbitration concerning indemnification of liabilities assigned during the 2015 spin-off. The parties agreed to jointly terminate the pending arbitration and not to bring future claims regarding the Separation Agreement or the MOU outside of arbitration. Additional agreements reflecting the MOU terms are expected to be finalized by February 28, 2021.
Outlook, Risks, and Contingencies
Management notes that the settlement is a compromise and not an admission of liability. The filing includes standard forward-looking statements regarding risks that could impact future performance, including:
- Outcomes of pending or future litigation related to PFAS or PFOA, including personal injury and natural resource damage claims.
- The extent and cost of ongoing and potential future remediation obligations.
- Changes in laws and regulations applicable to PFAS chemicals.
- The performance of DuPont and Corteva regarding their obligations under the sharing agreement.
- The terms of any final agreement formalizing the sharing arrangement.
The filing does not provide updated revenue, profit, cash flow, or margin guidance for the current fiscal year.
Investor Verification Checklist
- Verify the final terms of the definitive agreements expected by February 28, 2021, which will formalize the MOU.
- Monitor the status of the Travis and Julie Abbott v. E. I. du Pont de Nemours and Company case, which was explicitly excluded from the $83 million settlement.
- Track the actual funding of the escrow account against the scheduled $100 million and $50 million annual deposits.
- Review future 10-Q and 10-K filings for updates on the $4 billion "Qualified Spend" threshold and any changes to the liability sharing cap.
- Assess the impact of potential regulatory changes on PFAS chemicals on future remediation costs and liability exposure.